Karin Wehlin
Chief Executive Officer at DIAGONAL BIO AB
Profile
Karin Wehlin is the founder of EQL Pharma AB, which was founded in 2006.
She is currently the Chief Executive Officer at Diagonal Bio AB since 2024.
Previously, she held the position of Chief Executive Officer at LU Food Science AB, BoMill AB, and Respiratorius AB.
Ms. Wehlin obtained an MBA from the University of Lund.
Karin Wehlin active positions
| Companies | Position | Start |
|---|---|---|
| DIAGONAL BIO AB | Chief Executive Officer | 2024-02-27 |
Former positions of Karin Wehlin
| Companies | Position | End |
|---|---|---|
| BOMILL AB | Chief Executive Officer | - |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Chief Executive Officer | - |
| LU Food Science AB | Chief Executive Officer | - |
| EQL PHARMA AB | Founder | - |
Training of Karin Wehlin
| University of Lund | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| EQL PHARMA AB | Health Technology |
| DIAGONAL BIO AB | Health Technology |
 | Health Technology |
| BOMILL AB | Technology Services |
| Private companies | 1 |
|---|---|
| LU Food Science AB |
- Stock Market
- Insiders
- Karin Wehlin